Kukje Pharma Co., Ltd.
KSC: 002720.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Tae-hoon Nam
- Employees
- 242
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2005
- Market cap
- ₩91.9B
- Website
- https://www.kukjepharm.co.kr
Loading 002720…
Loading profile data…Frequently asked questions about 002720
What does Kukje Pharma Co., Ltd. (002720.KS) do?
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones...
Where does 002720.KS trade?
Kukje Pharma Co., Ltd. (002720.KS) trades on the Korea Exchange.
What sector is 002720.KS in?
Kukje Pharma Co., Ltd. (002720.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kukje Pharma Co., Ltd.?
Tae-hoon Nam is the chief executive officer of Kukje Pharma Co., Ltd. (002720.KS).
Where is Kukje Pharma Co., Ltd. headquartered?
Kukje Pharma Co., Ltd. is headquartered in South Korea.
Does 002720.KS pay a dividend?
Yes — Kukje Pharma Co., Ltd. (002720.KS) paid a trailing twelve-month dividend of KRW 30.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002720.KS go public?
Kukje Pharma Co., Ltd. (002720.KS) completed its initial public offering in 2005.